Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Buyer Trends and Structured Consumption Behavior Key consumer priorities include: Easier-to-finish meal formats High protein and nutrient density Portion control and satiety support Digestive comfort and hydration Convenient, repeatable nutrition routines Consumers are increasingly seeking practical daily-use products rather than trend-driven diet solutions
Foundayo introduces a new oral GLP-1 option, offering all-day flexibility without meal restrictions
Wegovy has a well-established evidence base for obesity treatment, whereas topiramate carries significant neurological, metabolic, and teratogenic risks that make it unsuitable as a weight loss option
Some therapies have limited efficacy
the placebo group lost an average of 2.8kg
Moreover, ACTL6A overexpression relieved the inhibited GC cell proliferation caused by ACTL6A expression knockdown (Supplementary Fig 1c, d)
US$ 28.59
US$ 25.67
US$ 20.47
US$ 22.23
US$ 27.71
US$ 25.28
US$ 23.81
US$ 28.69
US$ 23.08
US$ 26.33
US$ 25.44
